The case pertains to a Company Petition filed by the Liquidator of Adamas India Pharmaceuticals Private Limited under Section 59(7) of the Insolvency and Bankruptcy Code, 2016, seeking a direction for the dissolution of the Corporate Person/Company. The company, a subsidiary of Adamas Pharmaceuticals Inc., U.S.A., initiated voluntary liquidation proceedings. The management proposed to terminate its business activities and initiate members' voluntary winding up. A special resolution was passed, and the ROC and IBBI were duly informed. The liquidator made public announcements, informed various departments, and prepared a preliminary report. The company had no assets to be disposed of and no outside liabilities. The liquidator furnished annual status reports and closed
…Adamas India Pharmaceuticals Pvt Ltd, a subsidiary of Adamas Pharmaceuticals Inc., U.S.A., was incorporated on 2007-05-04. The company's authorized capital was Rs. 5,00,000, divided into 50,000 equity shares of Rs. 10 each. The issued and paid-up capital was Rs. 1,00,000, divided into 10,000 equity shares of Rs. 10 each. The company's main objects included undertaking pharmaceutical research and development activities. The management proposed to terminate business activities and initiate members' voluntary winding up. The Board of Directors decided to voluntarily liquidate the company on 2018-03-20 and executed a declaration under Section 59(3) of the IBC, 2016. A special resolution was obtained on 2018-04-02. The company informed the ROC and IBBI about the special
…Sign in to view the parties.
Adamas India Pharmaceuti…
The Board of Directors…
The case pertains to a Company Petition filed by the Liquidator of Adamas India Pharmaceuticals Private Limited under Section 59(7) of the Insolvency and Bankruptcy Code, 2016, seeking a direction for the dissolution of the Corporate Person/Company. The company, a subsidiary of Adamas Pharmaceuticals Inc., U.S.A., initiated voluntary liquidation proceedings. The management proposed to terminate its business activities and initiate members' voluntary winding up. A special resolution was passed, and the ROC and IBBI were duly informed. The liquidator made public announcements, informed various departments, and prepared a preliminary report. The company had no assets to be disposed of and no outside liabilities. The liquidator furnished annual status reports and closed
…Adamas India Pharmaceuticals Pvt Ltd, a subsidiary of Adamas Pharmaceuticals Inc., U.S.A., was incorporated on 2007-05-04. The company's authorized capital was Rs. 5,00,000, divided into 50,000 equity shares of Rs. 10 each. The issued and paid-up capital was Rs. 1,00,000, divided into 10,000 equity shares of Rs. 10 each. The company's main objects included undertaking pharmaceutical research and development activities. The management proposed to terminate business activities and initiate members' voluntary winding up. The Board of Directors decided to voluntarily liquidate the company on 2018-03-20 and executed a declaration under Section 59(3) of the IBC, 2016. A special resolution was obtained on 2018-04-02. The company informed the ROC and IBBI about the special
…Adamas India Pharmaceuti…
The Board of Directors…